This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: novo-nordisk-inc.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Reading this · An LD-2 reports either a fee the registrant charged or expenses it spent, never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. The expenses basis is what an organization lobbying on its own behalf files — usually for itself, sometimes for an affiliate under a different name — so a name on the second list is the client the filing names, not necessarily a claim that the registrant lobbied for someone else's account. Across every relationship on file — not just those shown — this registrant reported $0 in fees and $56.8M in expenses.
BUD · 1 client
69 filings
$56.8M on those filings
Taxation/Internal Revenue Code
TAX · 1 client
53 filings
$41.7M on those filings
Pharmacy
PHA · 1 client
51 filings
$32.8M on those filings
Copyright/Patent/Trademark
CPT · 1 client
49 filings
$41.7M on those filings
Trade (domestic/foreign)
TRD · 1 client
27 filings
$18.8M on those filings
Defense
DEF · 1 client
21 filings
$15.9M on those filings
Government Issues
GOV · 1 client
12 filings
$6.7M on those filings
Veterans
VET · 1 client
11 filings
$8.3M on those filings
Law Enforcement/Crime/Criminal Justice
LAW · 1 client
6 filings
$3.6M on those filings
Tariff (miscellaneous tariff bills)
TAR · 1 client
5 filings
$7.5M on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore money on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
24 filings1 client · through 2026
Sonya Clay24 filings1 client · through 2026
Amy Wotring23 filings1 client · through 2019
Christopher Porter22 filings1 client · through 2015
Christopher Mcgowen22 filings1 client · through 2014
Michael Mawby18 filings1 client · through 2013
Amanda MakkiCovered position: US Senator Lisa Murkowski (R-AK)16 filings1 client · through 2017
Stephen Mcgill15 filings1 client · through 2012
Amy Catherine Thienel13 filings1 client · through 2015
Chad YelinskiCovered position: Deputy Chief of Staff, Senator Tedd Budd12 filings1 client · through 2026
Al LyttonCovered position: U.S. Representative Renee Ellmers (NC-02)12 filings1 client · through 2020
Preston Owen BellCovered position: Deputy Chief of Staff, Congressman Richard Hudson10 filings1 client · through 2023
Shaylah Nunn10 filings1 client · through 2013
Rosalyn KumarCovered position: Deputy Chief of Staff, Rep. Debbie Wasserman Schultz; Tax Counsel, Senator Stabenow4 filings1 client · through 2026
Moriah Merkel4 filings1 client · through 2012
Covered positions · 8 of 19 lobbyists named on these filings disclosed a prior government post. A covered official position is the LD-2 field a lobbyist uses to report having held one; the text is reproduced exactly as filed.
Denmark
21 filings
through 2015
Novo A/S (Owns 26.5% of Nn A/S)
Denmark
4 filings
through 2018
Novo Nordisk Fonden (Ultimate Parent Company)
Denmark
4 filings
through 2018
Registrant Is a Wholly-Owned Subsidiary of Novo Nordisk US Which Is Wholly-Owned by Novo Nordisk A/S.
Denmark
2 filings
through 2018
Registrant Is a Wholly-Owned Subsidiary of Novo Nordisk US Which Is Wholly Owned by Novo Nordisk A/S.
Denmark
2 filings
through 2016
Novo A/S (Owns 26.5% of Nn A/S).
Denmark
1 filing
through 2017
Novo Nordisk Fonden (Ultimate Parent Company).
Denmark
1 filing
through 2017
Registrant Is a Wholly-Owned Subsidiary of Novo Nordisk US Which Is Wholly-Owned by Novo Nordisk A/S
Denmark
1 filing
through 2017
What this discloses · An LD-2 reports foreign entities that hold an interest in, or contribute to, the client — so these are foreign interests behind the organizations this registrant files for, not owners of the registrant itself. Disclosure is a reporting requirement, not an allegation.
